Stanley Perlman Selected Research

asapiprant

1/2022	Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19.
4/2021	Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stanley Perlman Research Topics

Disease

66	Infections 01/2022 - 09/2005
29	COVID-19 10/2022 - 01/2020
18	Coronavirus Infections 01/2022 - 09/2005
16	Virus Diseases (Viral Diseases) 01/2022 - 06/2005
12	Severe Acute Respiratory Syndrome 01/2022 - 09/2005
10	Demyelinating Diseases (Demyelinating Disease) 11/2020 - 07/2002
8	Inflammation (Inflammations) 01/2022 - 10/2011
7	Pneumonia (Pneumonitis) 01/2022 - 01/2014
4	Encephalitis (Encephalitis, Rasmussen) 08/2014 - 10/2003
3	Encephalomyelitis (Myeloencephalitis) 10/2021 - 07/2011
3	Human Influenza (Influenza) 01/2021 - 11/2006
3	Weight Loss (Weight Reduction) 01/2020 - 02/2015
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 10/2015
2	Lung Injury 01/2021 - 04/2015
2	Acute Lung Injury 01/2019 - 01/2017
2	West Nile Fever 12/2016 - 08/2016
2	Emerging Communicable Diseases (Emerging Infectious Diseases) 03/2016 - 02/2016
2	Multiple Sclerosis 03/2005 - 02/2004
1	Breakthrough Infections 05/2022
1	COVID-19 breakthrough infections 05/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2022
1	Rheumatic Diseases (Rheumatism) 05/2022
1	Pathologic Processes 01/2022
1	Reinfection 01/2022
1	Vesicular Stomatitis 01/2022
1	Shock 01/2021
1	Malaria 01/2020

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 10/2022 - 09/2005
25	VaccinesIBA 05/2022 - 04/2014
20	CytokinesIBA 01/2022 - 02/2004
15	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2007
11	Neutralizing AntibodiesIBA 05/2022 - 10/2002
9	EpitopesIBA 01/2022 - 02/2004
8	ChemokinesIBA 01/2020 - 02/2004
7	Pharmaceutical PreparationsIBA 01/2022 - 09/2015
7	InterferonsIBA 01/2022 - 10/2010
6	AntibodiesIBA 10/2022 - 03/2005
5	Interleukin-10 (Interleukin 10)IBA 01/2020 - 03/2011
5	AntigensIBA 01/2018 - 04/2003
4	Messenger RNA (mRNA)IBA 10/2022 - 04/2015
4	COVID-19 VaccinesIBA 05/2022 - 01/2020
4	Prostaglandin D2IBA 01/2022 - 01/2017
4	Angiotensin-Converting Enzyme 2IBA 01/2022 - 01/2007
4	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 05/2014
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 10/2010
4	Interferon-gamma (Interferon, gamma)IBA 01/2021 - 07/2002
4	RNA (Ribonucleic Acid)IBA 01/2018 - 09/2015
3	EndoribonucleasesIBA 01/2022 - 01/2017
3	Glycoproteins (Glycoprotein)IBA 01/2022 - 03/2008
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2007
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2022 - 12/2021
2	Therapeutic UsesIBA 01/2022 - 07/2011
2	asapiprantIBA 01/2022 - 04/2021
2	EicosanoidsIBA 01/2022 - 04/2021
2	Uridylate-Specific EndoribonucleasesIBA 01/2022 - 12/2021
2	Phospholipases (Phospholipase)IBA 01/2022 - 10/2015
2	Prostaglandins DIBA 04/2021 - 12/2011
2	InterleukinsIBA 01/2021 - 01/2020
2	nicotinamide-beta-ribosideIBA 12/2020 - 10/2020
2	EnzymesIBA 12/2020 - 10/2020
2	NAD (NADH)IBA 12/2020 - 10/2020
2	Niacinamide (Nicotinamide)FDA LinkGeneric 12/2020 - 10/2020
2	Immunoglobulin G (IgG)IBA 01/2019 - 03/2016
2	Viral ProteinsIBA 01/2017 - 02/2007
2	Subunit VaccinesIBA 01/2017 - 03/2016
2	Immunoglobulins (Immunoglobulin)IBA 01/2017 - 12/2016
2	Interferon Type IIBA 02/2016 - 02/2016
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2013 - 06/2005
2	Chemotactic FactorsIBA 03/2013 - 06/2005
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 03/2009 - 07/2006
1	mRNA VaccinesIBA 10/2022
1	Rituximab (Mabthera)FDA Link 05/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	Lipid NanoparticlesIBA 01/2022
1	2-5A-dependent ribonuclease (RNase L)IBA 01/2022
1	prostaglandin D2 receptorIBA 01/2022
1	Interferon LambdaIBA 01/2022
1	Liposomes (Liposome)IBA 01/2022
1	Phospholipases A2 (Phospholipase A2)IBA 01/2022
1	oridoninIBA 12/2021
1	pifithrinIBA 01/2021
1	AldehydesIBA 01/2021
1	Chemokine CXCL10IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Codon (Codons)IBA 01/2021
1	Hemagglutinins (Hemagglutinin)IBA 01/2021
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	CyclohexaneIBA 01/2021
1	SolutionsIBA 11/2020
1	Sialic AcidsIBA 11/2020
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Viral VaccinesIBA 01/2020
1	Polychlorinated Dibenzodioxins (TCDD)IBA 01/2020

Therapy/Procedure

16	Therapeutics 01/2022 - 01/2007
1	Personal Protective Equipment 01/2021
1	Artificial Respiration (Mechanical Ventilation) 10/2020